Drug Information

Drug General Information
Drug ID
D05RSC
Former ID
DNCL003077
Drug Name
Sofinicline
Drug Type
Small molecular drug
Indication Attention deficit hyperactivity disorder [ICD9: 314; ICD10:F90] Phase 2 [532857]
Company
Abbott Laboratories; NeuroSearch
Structure
Download
2D MOL

3D MOL
Formula
C10H11Cl2N3
Canonical SMILES
C1C2CN(CC2N1)C3=CC(=C(N=C3)Cl)Cl
InChI
1S/C10H11Cl2N3/c11-8-1-7(3-14-10(8)12)15-4-6-2-13-9(6)5-15/h1,3,6,9,13H,2,4-5H2/t6-,9+/m0/s1
InChIKey
MBQYQLWSBRANKQ-IMTBSYHQSA-N
PubChem Compound ID
10131048
PubChem Substance ID
15122001, 22533786, 39969478, 80292845, 96026062, 103542308, 104096101, 135261932, 137034285, 141518041, 198974095, 223982162, 226949222, 245022591, 251962934
Target and Pathway
Target(s) Nicotinic ACh receptor alpha 4/beta 2 Target Info Modulator [532857]
References
Ref 532857Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder. Expert Opin Investig Drugs. 2014 Aug;23(8):1157-63.
Ref 532857Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder. Expert Opin Investig Drugs. 2014 Aug;23(8):1157-63.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.